Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

PLZF Regulates CCR6 and Is Critical for the Acquisition and Maintenance of the Th17 Phenotype in Human Cells.
Daclizumab for relapsing remitting multiple sclerosis.
A case of acute disseminated encephalomyelitis associated with hepatitis C virus infection.
Acquired channelopathies as contributors to development and progression of multiple sclerosis.
Genetic control of nerve conduction velocity may influence multiple sclerosis phenotype.
Multiple sclerosis and seizures: incidence and prevalence over 40 years.
Simvastatin treatment does not protect retinal ganglion cells from degeneration in a rat model of autoimmune optic neuritis.
Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease.
Association of Missense Mutations of Mediterranean Fever (MEFV) Gene with Multiple Sclerosis in Turkish Population.
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases.
Anorexia heralding the onset of neuromyelitis optica.
Immune modulation by a tolerogenic MOG10-60 containing fusion protein in the marmoset experimental autoimmune encephalomyelitis model.
Sleep and oligodendrocyte functions.
Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells.
Care of patients with multiple sclerosis.
Expanded Disability Status Scale (EDSS) estimation in multiple sclerosis from posturographic data.
2-BFI ameliorates EAE-induced mouse spinal cord damage: Effective therapeutic time window and possible mechanisms.
Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis.
Aggregation of MBP in chronic demyelination.
Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis (SIMCOMBIN)
Validation survey of the impact of urinary incontinence (IIQ-7) and inventory of distress urogenital (UDI-6) - the short scales - in patients with multiple sclerosis.
Comment on Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin.
Current status of myelin replacement therapies in multiple sclerosis.
Growth arrest specific gene 6 protein concentration in cerebrospinal fluid correlates with relapse severity in multiple sclerosis.

Pages